Clinical Trials Directory

Trials / Completed

CompletedNCT03466255

Early Detection of Cardiovascular Disease

Vascular Imaging as a Barometer for the Early Detection of Cardiovascular Disease

Status
Completed
Phase
Study type
Observational
Enrollment
610 (actual)
Sponsor
Dr. Amer Johri · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators plan to evaluate the correlation between carotid plaque enhancement on Contrast-enhanced ultrasound (CEUS), significant coronary artery disease (CAD), and cardiovascular (CV) outcomes in a systematic manner. The investigators hypothesize that increased levels of CEUS-detected vulnerable carotid plaque will be predictive of CV risk determined by angiography and future cardiovascular events.

Detailed description

Study Design: The investigators will conduct a prospective, single-center, observational study at the Cardiovascular Imaging Network at Queen's (CINQ, www.CINQLab.com). This facility allows a CEUS protocol to be conducted on the same day as the angiogram. It is anticipated that 100 participants can be recruited per month with a total target enrolment of up to 1000 participants. Objectives 1. To determine the test characteristics (sensitivity, specificity, negative/positive predictive values) of carotid plaque by CEUS (Definity(R)) for predicting significant CAD (≥50% stenosis) in participants referred for angiography 2. To determine the test characteristics (sensitivity, specificity, predictive values) of carotid plaque by CEUS for predicting future CV events, such as death, stroke, myocardial infarction, and cardiovascular interventions.

Conditions

Interventions

TypeNameDescription
OTHERUltrasoundContrast-enhanced ultrasound (CEUS)

Timeline

Start date
2016-12-06
Primary completion
2021-06-08
Completion
2022-01-11
First posted
2018-03-15
Last updated
2022-06-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03466255. Inclusion in this directory is not an endorsement.